Dermatology
News, opinions and meeting coverage in dermatology.
— Risks identified in both the peripartum period and long-term
Latest in Dermatology
Veep in "excellent health," doctor says, with history that includes seasonal allergies, urticaria
Differences in absolute, relative risk highlight complexities of analyzing rare events
Two-year survival in second line for patients with BRAF/NRAS wild-type tumors
Study findings suggest cold storage may prevent breakdown into carcinogen
Two-year survival in second line for patients with BRAF/NRAS wild-type tumors
Study findings suggest cold storage may prevent breakdown into carcinogen
Dermatology Case Studies
Long-ignored patches of progressively hardening skin finally receive a rare diagnosis
Treatment-resistant juvenile dermatomyositis resolved by targeting elevated interferon-beta
Incision sites were itchy, painful, red, and oozing and were not showing signs of healing
More in Dermatology
Knowing what to look for can mean the difference between life and death
Health news and commentary gathered by Ƶ staff
Only a minority of patients adhered to SUNTRAC screening recommendations
A 29-year-old woman visited the doctor for a painful rash that developed on her arm 1 day after working on a landscaping project that involved pulling weeds under intense sunlight. Can you diagnose the patient?
But only a minority achieved minimal disease activity within 16 weeks
38% of patients treated with IL-13 blocker achieved clear or almost-clear skin at 16 weeks
Parents and child psychologists worry about the trend's effects on girls' mental health
However, this benefit was lost if smoking was resumed
A 55-year-old man visited his doctor for a growth that developed on his right leg, at the site of previous surgery, 2 months prior. Can you diagnose the patient?
More data for discussion of controversial association between steroids, immunotherapy
Also in TTHealthWatch: computer interfaces for communication in people with ALS
Long-term maintenance therapy is necessary, researchers caution
Nemolizumab significantly improved itch, nodules, and sleep disturbance at 16 weeks
